ArticleCancers2024

Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach.

Thomas Büttner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.